Welcome! Get 20% off this month for our immunoassay and flow cytometry services.
Immuno-oncology is a most exciting new development in cancer research and has emerged as a compelling area of personalized medicine with its tremendous potential to harness our powerful immune system to target and destroy cancer cells with few side effects. Researchers are exploring the complex relationship between tumor and the immune system within the tumor microenvironment in order to discover new immuno-oncology targets and therapies. A deep understanding of these targets is the key to unlocking the next blockbuster immunotherapy, kickstarting our immunity to fight cancer. Our -immuno-oncology solutions span the entire drug discovery workflow, from drug screening, pre-clinical efficacy, to evaluation of human tumor samples from clinical trials. Our immune cell function assays, along with our immunoassays, are the perfect fit for these researches and developments, providing a broad range of highly reproducible, sensitive solutions for high-throughput screening, biomarker validation and efficacy studies.
T cell activation